Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The three-year, $500,000 award will support research that will examine the effects of GLP-1 medication use on obesity care, health disparities, and population health outcomes in the U.S
Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives
Zepbound: An FDA-approved branded tirzepatide injection for chronic weight management
Chronic sleep deprivation disrupts leptin and ghrelin balance, increasing hunger signals and reducing satiety responses
US$ 24.09
US$ 22.50
US$ 21.87
US$ 27.40
:quality(75):max_bytes(102400)/https://assets.iprofesional.com/assets/jpg/2025/06/598505_landscape.jpg)
US$ 25.33
US$ 22.72
